在Helicobacter pylori根除后患者的益生菌混合物:现实生活中的经验
Salvatore E Aragona1, Carlo Fabbri2, Giovanni Cammarota3
1Unit of General Surgery, ASST Melegnano Martesana Presidio Melzo, Milan, Italy.
Minerva gastroenterology
|March 27, 2024
概括
用Abivisor®补充益生菌有效降低了消化系统症状,并在 Helicobacter pylori 根除后改善了肠道健康. 这种干预迅速恢复了微生物群平衡,并安全地缓解了患者的投诉.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 杆菌根除往往导致消化功能失调和相关症状.
- 正在探索益生菌补充剂,以抵消根除后的微生物失衡.
- 恢复肠道平衡可能会缓解H. pylori治疗后的症状.
研究的目的:
- 评估Abivisor®在消除H. pylori后的消化系统症状管理中的有效性和安全性.
- 评估Abivisor®对症状严重程度和患者幸福感的影响.
- 为了确定Abivisor®是否可以恢复微生物群的平衡.
主要方法:
- 一项随机对照试验,涉及H. pylori根除后的患者.
- 组A每天接受Abivisor® (Lacticaseibacillus rhamnosus LR06,Lactiplantibacillus pentosus LPS01,Lactiplantibacillus plantarum LP01,N-乙囊) 在60天的时间里.
- 在多个时间点使用视觉模拟尺度测量症状严重程度.
主要成果:
- 在60天的时间里,Abivisor®显著降低了肠道症状的存在和严重程度.
- 与对照组相比,在Abivisor®组中观察到症状患者的更快,更显著的减少.
- 所有参与者都能很好地容忍食品补充剂.
结论:
- 艾比维索 (Abivisor®) 显示出作为H. pylori根除患者有效和安全的治疗选择的潜力.
- 益生菌干预可能有助于减轻根除后的消化障碍.
- 阿比维索 (Abivisor) 支持恢复肠道健康和缓解症状.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
390
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
390
01:26Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
116
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
116
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
409
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
409
01:30Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
01:23Gastritis III: Clinical Manifestations and Management
235
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
235